BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals Market Cap

BioCryst Pharmaceuticals has a market cap or net worth of $2.46 billion as of March 19, 2026. Its market cap has increased by 41.68% in one year.

• Market Cap: 2.46B
• Enterprise Value: 2.61B
• 1-Year Change: 41.68%
• Ranking: #1880
• Category: Mid-Cap
• Stock Price: $9.81

Market Cap Chart

Since December 1, 1998, BioCryst Pharmaceuticals's market cap has increased from $100.40M to $2.46B, an increase of 2,350.55%. That is a compound annual growth rate of 12.43%.

Market Cap History

Date	Market Cap	% Change
Mar 18, 2026	2.30B	39.89%
Dec 31, 2025	1.64B	5.43%
Dec 31, 2024	1.56B	26.96%
Dec 29, 2023	1.23B	-42.68%
Dec 30, 2022	2.14B	-14.12%
Dec 31, 2021	2.49B	89.46%
Dec 31, 2020	1.32B	245.25%
Dec 31, 2019	381.00M	-56.94%
Dec 31, 2018	884.80M	83.11%
Dec 29, 2017	483.20M	3.49%
Dec 30, 2016	466.90M	-38.31%
Dec 31, 2015	756.80M	-13.40%
Dec 31, 2014	873.90M	94.59%
Dec 31, 2013	449.10M	522.02%
Dec 31, 2012	72.20M	-35.36%
Dec 30, 2011	111.70M	-51.92%
Dec 31, 2010	232.30M	-7.38%
Dec 31, 2009	250.80M	378.63%
Dec 31, 2008	52.40M	-77.65%
Dec 31, 2007	234.50M	-30.60%
Dec 29, 2006	337.90M	-23.72%
Dec 30, 2005	443.00M	252.71%
Dec 31, 2004	125.60M	3.37%
Dec 31, 2003	121.50M	614.71%
Dec 31, 2002	17.00M	-75.61%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Amneal Pharmaceuticals	3.76B
Kiniksa Pharmaceuticals International,	3.56B
Liquidia	3.15B
Supernus Pharmaceuticals	2.88B
Prestige Consumer Healthcare	2.88B
HUTCHMED (China)	2.47B
Phibro Animal Health	2.07B
Bausch Health Companies	1.86B